Raman, Puneet
Botrus, Gehan
Bekaii-Saab, Tanios
Chapter History
First Online: 19 March 2022
Compliance with Ethical Standards
: <b>Conflict of Interest</b>: Puneet Raman, M.D., declares no conflicts of interest that might be relevant to the contents of this manuscript.
: Gehan Botrus, M.D., Ph.D., declares no conflicts of interest that might be relevant to the contents of this manuscript.
: Tanios S. Bekaii-Saab, M.D., declares: Research Funding (to institution): Boston Biomedical, Bayer, Amgen, Merck, Celgene, Lilly, Ipsen, Clovis, Seattle Genetics, Array Biopharma, Genentech, Abgenomics, Incyte, and eBMS. Consulting (to institution): Ipsen, Array Biopharma, Seattle Genetics, Bayer, Genentech, Incyte, and Merck. Consulting (to self): Boehringer Ingelheim, TreosBio, and Sobi. IDMC/DSMB (to self): AstraZeneca, Exelixis, Lilly, PanCan, and 1Globe. Scientific Advisory Board: Imugene, Immuneering, and Sun Biopharma. Inventions/Patents: WO/2018/183488 and WO/2019/055687.